Join
Live feed
·
PRReleasevia Quantisnow
ContraFect Corporation logo

ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study

ByQuantisnow·Wall Street's wire, on your screen.
CFRX· ContraFect Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CFRX (ContraFect Corporation) and more on Quantisnow.